We evaluated the clinical outcome measures of fixture loss and skin reactions in older-adult users of percutaneous bone-anchored hearing aids (BAHAs).
INTRODUCTION
About 30 years ago, the bone-anchored hearing aid (BAHA; Cochlear Bone Anchored Solutions AB, Göteborg, Sweden) was developed. It comprises a bone conduction hearing aid connected to a percutaneous titanium implant in the temporal bone. 1, 2 The BAHA was first applied to patients with significant bilateral conductive or mixed hearing loss in whom conventional solutions had failed. 1, 3, 4 As a result of its success, the indications have been extended. Children have been included, as well as patients with moderate mental retardation. [5] [6] [7] [8] [9] Other indications for BAHA treatment are unilateral inner ear deafness (BAHA CROS [contralateral routing of sound]) 10 and unilateral acquired and congenital conductive hearing impairment. [11] [12] [13] [14] The BAHA Softband was first introduced in 2001 as a transcutaneous device for infants and toddlers who were candidates for BAHA implantation. 15 Over the years, the surgical technique used to implant the percutaneous fixture and handle the soft tissue has been simplified. In adults and children (older than 10 years), the two-stage technique has been reduced to one stage. The application of a free skin graft has been abandoned. Nowadays, a pedicled thinned skin flap is used, or a simple longitudinal incision with maximal subcutaneous and periosteal tissue reduction. 4, [16] [17] [18] [19] In general, the aim is to achieve a thin, hairless skin site (fixed to the bone) around the percutaneous titanium implant to minimize skin reactions.
Depending on the BAHA implant center and the duration of follow-up, the rates of implant loss have varied from 3.5% to 17.4% in adults 4, 11, 16, [19] [20] [21] [22] [23] [24] and from 5.3% to 30% in children. 6, 7, [25] [26] [27] [28] [29] [30] [31] [32] [33] The cause of the wide variation in outcomes is still not well understood. Children are more vulnerable to implant loss, and differences have been found between age groups. 26, 29 Skin care around the BAHA implant is a difficult issue in children, because it is not always possible for them to perform skin care adequately. The same might also apply to the older-adult population because of various age-related problems such as visual impairment, decreased mobility of the fingers or hands, and lack of assistance.
In the literature, data on older-adult BAHA users are scarce. 34 Therefore, to investigate whether this group of BAHA users might be at more risk of implant loss and adverse skin reactions, we retrospectively analyzed these clinical outcomes in older-adult patients who received implants by the Nijmegen linear incision technique.
PATIENTS AND METHODS
Patients. The study cohort comprised 224 consecutive patients 60 years of age or older (111 men and 116 women) who had undergone implantation of a BAHA in Nijmegen between January 1, 1995, and May 1, 2007. The mean (±SD) age at implantation was 65 ± 6.5 years (range, 60 to 87 years).
Surgical Technique. Older-adult BAHA users were included in this retrospective study if they had undergone implantation by the simplified Nijmegen one-stage linear incision technique. This surgical technique consisted of a longitudinal incision of approximately 3 cm, 50 to 55 mm posterosuperior to the ear canal. After removal of the periosteum, the titanium implant was placed according to the one-stage technique described by Tjellström et al. 21 Subcutaneous tissue was reduced extensively over an area of approximately 2 cm around the incision. After wound closure, a pressure dressing provided hemostasis. 19 This linear incision surgical technique has been described by Mylanus and Cremers, 35 van der Pouw et al, 23 and de Wolf et al. 19 Over the years, three surgeons have been involved in the technique at our institution. Their combined results are presented below.
Case Analysis. Data were obtained from the medical files of the 224 older-adult BAHA users on age, gender, indication for a BAHA, type of implant (3 or 4 mm), type of ending of the drilled hole, possible (post)operative complications, implant failure, time of failure, skin reactions (Holgers grade), 36, 37 and duration of follow-up. The Holgers classification comprises five grades: 0) no irritation, 1) slight redness, 2) red and moist tissue, 3) granulation tissue, and 4) infection leading to removal of the abutment. A grade 2 or higher reaction was interpreted as an adverse skin reaction. In the literature, several reasons were mentioned for implant failure, such as failed osseointegration, infection, trauma, non-use because of progressive sensorineural hearing loss, and improved hearing after conventional ear surgery. 1, 16, 19, 20, 22, 38, 39 Pain rarely was given as the reason to remove the implant. 40, 41 Clinical outcomes were divided into 5-year subgroups according to the age of the patient at implantation.
Statistics. Comparisons of categorical variables were made with χ 2 tests or Fisher's exact test. Timeto-event analyses were conducted with the logrank test and Beslow test and Kaplan-Meier curves. SPSS version 16 (SPSS, Inc, Chicago, Illinois) and Prism Graph Pad 5 (GraphPad Software, La Jolla, California) were used. The level of significance (p) was 0.05.
RESULTS
Between January 1, 1995, and May 1, 2007, 224 older-adult patients had received 248 implants. In 12 patients, BAHAs had been placed bilaterally (n = 25). In 1 case, one of the bilateral BAHA implants had been placed by means of a skin graft technique; therefore, this implant was excluded from the analysis.
Chronic otitis media, ie, the conventional indication, was the cause of the hearing impairment in 202 patients (90.2%). Unilateral sensorineural hearing impairment was the indication in 21 patients (9.0%). A BAHA had been placed to achieve directional hearing in 1 patient (0.4%) with congenital unilateral conductive hearing impairment and in another patient (0.4%) with unilateral acquired conductive hearing impairment due to trauma.
During surgery, the drilled hole had ended in bone in 198 cases (80%), in dura in 22 cases (9%), and in a sigmoid sinus in 18 cases (7%). Only 10 observations were missing (4%). All of the implants were 4 mm except for one.
The mean follow-up of each titanium implant was 39 months (range, 0 to 144 months), with a mean of 4.8 ± 3.6 observations per implant. Table 1 shows the postoperative wound healing complications. Minor wound dehiscence was the most common complication. It took an average of 6.4 weeks (range, 2 to 10 weeks) of treatment to clear up. Moderate wound dehiscence occurred in 2 patients and took considerably longer to treat (35 and 19 weeks, respectively). The small skin lesion healed within 3 weeks. Figure 1 shows the causes of implant loss (n = 16; 6.5%) and the durations until implant loss. Failed osseointegration was the major cause in 9 of the 16 patients. Trauma was the cause in 6 cases. One patient lost 2 implants because of trauma. Another pa-
Survival curves of implant loss in older adults (248 implants), consecutive adults (150 implants), 19 and children (129 implants). 26 Events were fixture loss due to failed osseointegration, infection, and trauma. tient lost an implant because of failed osseointegration after 45 months of use and lost the replacement because of trauma after 32 months. After this loss, she received a second replacement. One implant was lost by a patient who had been treated with local radiotherapy to intracerebellar metastases from large cell lung carcinoma. Although 1 Holgers type 4 skin reaction occurred, no implants were lost because of infection in this group of older-adult BAHA users. None of the patients with lost implants had perioperative complications. Figure 2 19, 26 shows a Kaplan-Meier survival curve of all of the lost implants. The time-to-event analysis did not show any significant correlations between implant loss and age. The abutment had been removed in only 2 cases: one after 20 months of use because of chronic pain and the other after 4 months for psychological reasons following a period of neuralgic pain. Two other abutments were lost because of trauma, and another one became loose and was lost in association with a Holgers grade 4 skin reaction. The implants themselves were not lost, however.
During the total investigation period of 9,669 months, 1,180 observations had been made. In the majority of observations (1,046; 88.6%), no abnormalities were found ( Table 2) . To achieve a more clinically oriented presentation of the data, we noted the grade of the worst skin reaction per implant during follow-up. In 167 of the 248 implants (67.3%), no adverse skin reactions were observed. In 40 implants (16.9%), Holgers grade 2 or higher skin reactions was observed. More details are presented in Tables 2 and 3 . There were no significant differences between the age groups in the occurrence of the worst (highest-grade) skin reactions (Tables 4 and  5) .
Revision surgery of the skin surrounding the implant was performed for 6 implants (2.4%) in 5 patients (Table 6 ). In 1 of these patients, revision surgery was performed twice. The 3 lost abutments were replaced by means of second-stage surgery. In this older-adult population, no 8.5-mm abutments were used in the initial surgical procedure, or later to overcome severe skin reactions.
DISCUSSION
Loss of a BAHA implant can be the result of failed osseointegration, infection around the percutaneous implant, surgical removal because of severe pain at the implant site, or trauma. 16, [18] [19] [20] 22, 38, 40, 41 Children are the most vulnerable to failed osseointegration and trauma. In children 5 to 10 years of age, the rate of implant loss has been cited as 40%. 42 To the best 34 reported on a series of 131 implants that included 29 implants in older adults (at least 60 years of age); 25 of these 29 implants were BAHA implants, and 4 were auricular prosthesis implants. During a total follow-up of 3 to 17 years, the rate of implant loss was 20% (6 of 29). 34 This incidence was greater than that reported in the literature on the general BAHA population.
To gain greater insight into BAHA use in older adults, we analyzed the outcome of 224 older-adult patients who had received 248 implants with the Nijmegen linear incision technique. 19, 23, 35 Special attention was paid to the risk of losing an implant and adverse skin reactions that might have resulted from difficulties with cleaning the skin around the implant.
The most common reasons for implant loss in this population were failed osseointegration and trauma. Infection around the implant and the medical reasons reported in the literature were not among the causes of implant loss.
The rate of implant loss in this study was 6.5% (10 of the 248 implants). Time-to-event analysis did not reveal any significant correlation between the outcome and age.
In a previous study by the first author, the rate of implant loss was 9.3% (14 of the 150) in a consecutive series of 150 implants placed between January 1, 1996, and December 31, 1999. 19 All ages were represented in the population (56 ± 20 years [SD]), and the mean follow-up was 30 months (range, 0 to 159 months). In the current population, the mean follow-up of 39 months (range, 0 to 144 months) indicates that the rate of implant loss was comparable with earlier studies and was not disproportionally high in older adults as was previously mentioned by Drinias et al. 34 Figure 2 shows the present clinical data on implant loss due to failed osseointegration and trauma in the form of a Kaplan-Meier survival curve and includes previously published data from our clinic on implant loss (failed osseointegration, trauma, and infection) in a consecutive series of 150 implants 19 and a pediatric series of 129 implants. 26 There was no significant difference in the occurrence of implant loss between the current study and the consecutive series of adults and children (p > 0.09). However, a significant difference in implant loss was found between the pediatric series (n = 129) and the older adults in the current study (n = 248; p < 0.001). This finding once again confirms that children are at more risk of implant loss.
In the literature, the overall rates of implant loss in the general population range from 3.4% to 17.5%; 0.4% to 13.6% of losses were due to failed osseointegration. These populations contained adults and children (age range, 2 to 89 years). The mean follow-ups ranged from 1.9 to 6.7 years. 4, 16, 20, 22, 23, 38, 39 In the current study, the total rate of implant loss was 6.5% (16 of the 248); 3.6% of losses (10 of the 248) were due to failed osseointegration. The mean follow-up was 3.3 years. These outcomes are consistent with those reported in the literature. More research is needed to further determine the risk factors for BAHA implant loss in older adults.
Skin reactions around the implant are another ma-jor factor in the clinical outcome of BAHA surgery. In general, the rate of skin reactions around the percutaneous implant might be influenced by the surgical soft tissue technique applied. At our clinic, these outcomes were also negatively influenced by extended intervals between the outpatient checkups, which were due to the tendency of the patients to postpone their visits until they experienced problems around the implant.
In this study, 167 of the 248 implants (67.3%) remained free from any skin reaction. During the 1,180 observations, 51 implants (4.3%) had Holgers type 2 to 4 skin reactions ( Table 2) . A significant difference in the incidence of severe skin reactions was seen between the current study and the earlier Nijmegen BAHA studies on the consecutive series of patients in which the incidence of severe skin reactions was 6.5% (67 of 1,038 observations) 19 in the adults and 9.4% (43 of 457 observations) in the children (p = 0.003 and p < 0.001). 26 In the current study, the incidence of the highestgrade skin reaction per implant was 16.9% (40 of 248), whereas in the consecutive series, the incidence was as high as 26.7% (40 of 150). The significant difference in severe skin reactions between the current study and the consecutive series (p = 0.01) indicates that older adults had less-severe skin reac-tions around the implant and fewer events of severe skin reactions than the overall population studied at our clinic.
However, in the literature, the incidence rates of severe skin reactions per observation (Holgers grade 2 to 4) ranged from 1.7% to 6.5% in studies including more than 100 cases. 4, 19, 22, 23, 38, 39 Thus, the older adults in our study had comparable results.
Interestingly, tissue revision surgery was only performed around 6 implants in 5 patients in the current population, ie, 2.4% of all of the implants. This is a large difference compared to the previous Nijmegen publication on BAHA surgery, in which tissue revision surgery was performed on 19 cases in the consecutive population of 150 implants (12.6%; p < 0.001). 19 In the literature, the incidence of tissue revision surgery ranges from 3.2% to 12.6% in the overall BAHA population. 16, 19, 20, 23, 38 The incidence of revised surgical reduction of subcutaneous tissue was particularly high in the two more-recent studies on the skin flap technique: 14 of 177 (7.4%) and 11 of 149 (7.9%), respectively. 20, 38 These differences were significant (p = 0.04). Thus, the older adults in this study were at less risk of developing hypertrophic skin that required revision surgery around the implants. This finding can be explained by the nor- mal aging processes in the dermis: irreversible degeneration of tissue. 43 None of our population had a higher 8.5-mm abutment, although its application might have reduced the number of surgical revisions even further. More research into this specific topic is needed to draw reliable conclusions.
Besides long-term tissue complications, shortterm complications also occurred. With the use of the simplified linear incision technique, however, local skin necrosis did not occur in this population. Nevertheless, there were 12 cases of minor or moderate wound dehiscence around the implant (4.8%). Diabetes mellitus was present in 2 of these patients. It can be speculated that an important cause of wound dehiscence in specific populations is removal of the stitches at too early a stage. In general, stitches are removed within 7 days -possibly too early in the older-adult population with other general health problems.
These short-term complications of minor or moderate wound dehiscence around the implant were not observed in the other Nijmegen studies on the linear incision technique. 19, 23 In that technique, the exact location of the implant relative to the incision line is determined during surgery. The implant can be placed in the incision line or just beside it. In the lat- 530 de Wolf et al, Bone-Anchored Hearing Aid Surgery in Older Adults 530 ter case, the incision line is sutured and a small hole is punctured for the abutment at the implant site. It is possible that the occurrence of wound dehiscence was influenced by the location of the implant in relation to the incision in some of the older-adult patients with wound healing issues, such as those associated with diabetes mellitus. However, this hypothesis could not be tested retrospectively from the patient files. No additional surgery was needed in these patients.
In the literature, very few data are available on postoperative wound healing problems besides skin necrosis. Incidences range from 1% to 10.5% with the skin flap technique and reach 3% with the dermatome. 18, 20, 38, 44, 45 It should be emphasized that one of the advantages of the linear incision technique is the prevention of skin flap necrosis. However, special attention must be paid to the wound healing process in older-adult BAHA patients.
In conclusion, BAHA surgery in older adults had a favorable outcome. The rate of implant loss was similar to that in the overall BAHA population. The incidence of severe skin reactions was very low. There was less risk of developing hypertrophic skin around the implant, but a slightly increased tendency toward postoperative wound healing problems.
